Tigermed (03347) announced interim results: 截至2026年6月30日止六個月之中期業績公告, net profit attributable to owners RMB-4.1bn Title: 截至2026年6月30日止六個月之中期業績公告 Revenue: RMB37.1bn Net profit: RMB-1.9bn Profit attributable to owners: RMB-4.1bn
